7Baggers
 Zacks Research Upgrades Akebia Therapeutics (NASDAQ:AKBA) to Hold  MarketBeat Thu, 09 Jul 2026 12:27:44 GMT
 Akebia Therapeutics (AKBA) Proxy filing Summary  Quartr Wed, 08 Jul 2026 07:00:00 GMT
 AKBA - Akebia Therapeutics Inc Options  Finviz Mon, 06 Jul 2026 19:38:05 GMT
 Akebia awards 125,600 stock options to newly hired employees  Stock Titan Thu, 02 Jul 2026 20:05:00 GMT
 top akebia executive makes notable insider stock move  TipRanks Thu, 02 Jul 2026 02:20:37 GMT
 H.C. Wainwright reiterates Akebia stock rating on trial results  Investing.com Wed, 01 Jul 2026 12:08:08 GMT
 Akebia Therapeutics - Voice Trial Meets Stopp  Moomoo Tue, 30 Jun 2026 14:36:48 GMT
 Vafseo trial stops early after safety win in dialysis patients  Stock Titan Tue, 30 Jun 2026 12:00:00 GMT
 Akebia (AKBA) VOICE Trial Halted Following Positive Interim Resu  GuruFocus Tue, 30 Jun 2026 07:00:00 GMT
 Form 144 Akebia Therapeutics For: 29 June By Investing.com  Investing.com Nigeria Tue, 30 Jun 2026 03:12:56 GMT
 bronstein, gewirtz & grossman, llc is investigating akebia therap  The National Law Review Sun, 28 Jun 2026 15:55:31 GMT
 12 best low-priced pharma stocks to buy right now  Insider Monkey Sun, 28 Jun 2026 07:00:00 GMT
 Price to book forward of Akebia Therapeutics, Inc. – NASDAQ:AKBA  TradingView Sat, 27 Jun 2026 03:24:39 GMT
 price to sales forward of akebia therapeutics, inc. – nasdaq:akba  TradingView Fri, 26 Jun 2026 22:49:57 GMT
 akebia therapeutics, inc. actuals & estimates (nasdaq:akba)  TradingView Fri, 26 Jun 2026 08:56:43 GMT
 akba forecast — price target — prediction for 2027  TradingView Thu, 25 Jun 2026 14:18:09 GMT
 Akebia Therapeutics And 2 Other Promising Penny Stocks To Watch  simplywall.st Wed, 24 Jun 2026 07:00:00 GMT
 form 4 akebia ther for: 22 june by investing.com  Investing.com Nigeria Mon, 22 Jun 2026 23:09:24 GMT
 form 8k akebia ther for: 22 june by investing.com  Investing.com South Africa Mon, 22 Jun 2026 20:37:10 GMT
 [form 4] akebia therapeutics, inc. insider trading activity  Stock Titan Mon, 22 Jun 2026 20:20:33 GMT
 Akebia (NASDAQ: AKBA) director Myles Wolf granted RSUs and options  Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
 akebia therapeutics inc (akba) institutional confidence  TradingKey Mon, 22 Jun 2026 07:00:00 GMT
 q1 2026 akebia therapeutics inc earnings call transcript  GuruFocus Sat, 20 Jun 2026 02:05:35 GMT
 akebia therapeutics inc (akba) institutional confidence  TradingKey Thu, 18 Jun 2026 09:19:21 GMT
 akebia therapeutics (akba) agm 2026 summary  Quartr Wed, 17 Jun 2026 15:03:10 GMT
 akebia therapeutics inc annual shareholders meeting transcript  GuruFocus Wed, 17 Jun 2026 14:00:00 GMT
 akebia strengthens patent portfolio with new grant for vafseo (a  GuruFocus Wed, 10 Jun 2026 16:28:06 GMT
 Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio  Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
 akebia receives new patent, extension eligibility for vafseo  Investing.com Wed, 10 Jun 2026 07:00:00 GMT
 akebia therapeutics (akba) proxy filing summary  Quartr Sun, 07 Jun 2026 14:03:15 GMT
 h.c. wainwright reiterates akebia therapeutics stock rating at buy  Investing.com Thu, 04 Jun 2026 17:25:28 GMT
 new akebia hire receives 8,400 stock options at $1.02  Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
 AKBA - Akebia Therapeutics Inc Stock Price and Quote  Finviz Wed, 27 May 2026 15:48:34 GMT
 Promising Penny Stocks To Consider In May 2026  simplywall.st Tue, 26 May 2026 07:00:00 GMT
 akba technical analysis & stock price forecast  Intellectia AI Sun, 24 May 2026 09:23:32 GMT
 akba technical analysis & stock price forecast  Intellectia AI Fri, 22 May 2026 07:00:00 GMT
 akebia therapeutics earnings call: vafseo drives transition  TipRanks Wed, 20 May 2026 06:44:14 GMT
 akebia plunges 20% on muted q1 print  MSN Sun, 17 May 2026 17:54:24 GMT
 number of shareholders of akebia therapeutics, inc. – nasdaq:akba  TradingView Sun, 17 May 2026 15:06:57 GMT
 akebia plunges 20% on muted q1 print  MSN Wed, 13 May 2026 10:50:23 GMT
 akebia plunges 20% on muted q1 print  MSN Tue, 12 May 2026 14:18:07 GMT
 State Street (AKBA) reports 11.6M-share, 4.3% stake in Akebia  Stock Titan Tue, 12 May 2026 07:00:00 GMT
 hc wainwright issues negative estimate for akba earnings  MarketBeat Tue, 12 May 2026 07:00:00 GMT
 tradingkey  TradingKey Tue, 12 May 2026 03:57:38 GMT
 akebia plunges 20% on muted q1 print  MSN Mon, 11 May 2026 19:42:16 GMT
 akebia q1 2026 earnings preview  MSN Mon, 11 May 2026 10:35:02 GMT
 hc wainwright expects lower earnings for akebia therapeutics  MarketBeat Mon, 11 May 2026 07:00:00 GMT
 akebia plunges 20% on muted q1 print  MSN Sun, 10 May 2026 02:12:43 GMT
 akebia q1 2026 earnings preview  MSN Sat, 09 May 2026 13:29:10 GMT
 akebia therapeutics (akba) receives a buy from h.c. wainwright  The Globe and Mail Sat, 09 May 2026 11:04:00 GMT
 akebia plunges 20% on muted q1 print  MSN Sat, 09 May 2026 08:29:45 GMT
 akebia therapeutics, inc. (nasdaq:akba) q1 2026 earnings call transcript  Insider Monkey Sat, 09 May 2026 07:00:00 GMT
 akebia therapeutics balances vafseo momentum with headwinds  The Globe and Mail Sat, 09 May 2026 07:00:00 GMT
 akebia therapeutics | 10-q: q1 2026 earnings report  Moomoo Fri, 08 May 2026 17:12:58 GMT
 akebia therapeutics, inc. (nasdaq:akba): is breakeven near?  富途牛牛 Fri, 08 May 2026 14:51:35 GMT
 q1 2026 akebia therapeutics inc earnings call transcript  GuruFocus Fri, 08 May 2026 13:30:54 GMT
 akba sec filings - akebia therapeut 10-k, 10-q, 8-k forms  Stock Titan Fri, 08 May 2026 12:47:25 GMT
 akebia (akba) q1 2026 earnings transcript  The Motley Fool Fri, 08 May 2026 07:00:00 GMT
 akebia therapeutics balances vafseo momentum with headwinds  TipRanks Fri, 08 May 2026 07:00:00 GMT
 akebia therapeutics q1 2026 earnings call transcript  MarketBeat Fri, 08 May 2026 03:19:06 GMT
 akebia reports q1 eps (3c), consensus 0c  TipRanks Thu, 07 May 2026 18:12:54 GMT
 akebia therapeutics: q1 earnings snapshot  KVUE Thu, 07 May 2026 11:10:00 GMT

Akebia Therapeutics, Inc
(NASDAQ:AKBA) 

AKBA stock logo

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the tre...

Full Time Employees: 358
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends